Dubai, UAE, 08 Nov, 2023: Prognica Labs proudly welcomes Dr. Sten Vermund, a globally recognized figure in public health hailing from Yale University, as the newest addition to their distinguished advisory team.

Dr. Vermund’s illustrious career as a pediatrician and infectious disease epidemiologist at Yale University has been marked by groundbreaking contributions to the understanding and management of diseases prevalent in low and middle-income countries.

Renowned for his pioneering work on HIV-HPV interactions among women in Bronx methadone programs, Dr. Vermund’s research catalyzed a pivotal change in the 1993 CDC AIDS case surveillance definition. Furthermore, his innovative insights inspired the inception of cervical cancer screening programs integrated within HIV/AIDS initiatives worldwide.

Throughout his distinguished career, Dr. Vermund’s research has centered on pivotal themes including health care accessibility, adolescent sexual and reproductive health and rights, and the prevention of HIV transmission among diverse populations, including mother-to-child transmission.Venturing into the realms of health policy, Dr. Vermund has actively advocated for the sustainability of HIV/AIDS programs while extending their reach to non-communicable diseases. He has notably contributed to the global response and prevention strategies during the coronavirus pandemic and has been a driving force in developing the public health workforce.

His recent grants and projects encompass diverse regions and multifaceted initiatives, ranging from capacity-building for public health in Chad to molecular epidemiology studies for HIV in Kazakhstan, as well as COVID-19 vaccine research in the Dominican Republic and Connecticut. Moreover, Dr. Vermund’s commitment to community welfare is evident in his collaboration with schools and arts organizations, facilitating COVID-19 risk mitigation and institutional safety measures.

“We are honored to have Dr. Sten Vermund join our advisory team at Prognica Labs,” stated Khalid Shaikh, Founder CEO of Prognica Labs. “His wealth of expertise and unwavering dedication to global health initiatives align seamlessly with our mission to revolutionize health technology.”

Dr. Vermund’s appointment signifies a pivotal moment for Prognica Labs, amplifying the company’s dedication to pioneering advancements in health tech on a global scale.